Field of Research
Toward Public Health & Safe Society
R&D Center for Advanced Pharmaceuticals and Evaluation
- Advanced Toxicology Research
- Predictive Toxicology Research
- Non-Human Primate·Minipig Translational Toxicology Research
- Inhalation Biohazard Research
- Environmental·Human Risk Assessment Research
- Inhalation Toxicology Research for Airborne Risk Factors
- R&D Center for Advanced Pharmaceuticals and Evaluation
- Advanced Pharmaceuticals and Evaluation Research
R&D Center for Advanced Pharmaceuticals and Evaluation
The cradle of excellent research performance toward global stage
Under the goal of developing advanced toxicity and efficacy assessment platform and advanced disease treatment, we conduct research on alternative test method to develop toxicity prediction technology in accordance with the 4th industrial revolution such as stem cell-derived organoids
Advanced Pharmaceuticals and Evaluation
R&D Center for Advanced Pharmaceuticals and Evaluation develop a stem cell- derived organoids, artificial organs and bio-chip, Bio-signal technology based Mod of Action (MoA) analysis. Computer deep learning model development for sebum-based toxicity and efficacy prediction. Disease treatment development through bio-signal analysis, and drug carriers. Especially, we develop a disease model with new technology that imagification of spheroid structure in three dimensions, and observe the efficacy of new medicine and toxicity reaction accurately and fast to contribute to not only improvement of public health, but also provide technology to small and medium businesses to occupy global market.
R&D Center for Advanced Pharmaceuticals and Evaluation
-
In Vivo system rarefaction composition and the rarefaction method of vivo system based on this
- Applicable to various tissues such as brain, liver, lung without any damage, supplement limitations such as existing discoloration and bubble forming. and localize all technology and materials
- Completed patent registration to America and Japan, and plan to advance to overseas market
- Technical transfer to Binaree Inc.
-
Establish a bio-sensor platform technology for three dimensional cell medicine screening that applied patternized conductive carbon nanotube
- Systematically introduce the line patternization process of carbon nanotube, the conductive nano ingredient
- Improve the semiconducting effect of carbon nanotube
- Prepare the foundation of sensing platform for 3D cell spheroid
Head of R&D Center for Advanced Pharmaceuticals and Evaluation
Gi Seok Kim E-mail. idkks@kitox.re.kr
Gi Seok Kim E-mail. idkks@kitox.re.kr
Toward Public Health & Safe Society